Delva A - Search Results

1

Biodistribution and dosimetry in human healthy volunteers of the PET radioligands [¹¹C]CHDI-00485180-R and [¹¹C]CHDI-00485626, designed for quantification of cerebral aggregated mutant huntingtin.

Delva A, Koole M, Serdons K, Bormans G, Liu L, Bard J, Khetarpal V, Dominguez C, Munoz-Sanjuan I, Wood A, Skinbjerg M, Wang Y, Vandenberghe W, Van Laere K. Delva A, et al. Eur J Nucl Med Mol Imaging. 2022 Dec;50(1):48-60. doi: 10.1007/s00259-022-05945-z. Epub 2022 Aug 24. Eur J Nucl Med Mol Imaging. 2022. PMID: 36001116

2

Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.

Van Weehaeghe D, Ceccarini J, Delva A, Robberecht W, Van Damme P, Van Laere K. Van Weehaeghe D, et al. Among authors: delva a. J Nucl Med. 2016 Aug;57(8):1238-43. doi: 10.2967/jnumed.115.166272. Epub 2016 Mar 3. J Nucl Med. 2016. PMID: 26940764 Free article.

3

Quantification and discriminative power of ¹⁸F-FE-PE2I PET in patients with Parkinson's disease.

Delva A, Van Weehaeghe D, van Aalst J, Ceccarini J, Koole M, Baete K, Nuyts J, Vandenberghe W, Van Laere K. Delva A, et al. Eur J Nucl Med Mol Imaging. 2020 Jul;47(8):1913-1926. doi: 10.1007/s00259-019-04587-y. Epub 2019 Nov 27. Eur J Nucl Med Mol Imaging. 2020. PMID: 31776633

4

Loss of Presynaptic Terminal Integrity in the Substantia Nigra in Early Parkinson's Disease.

Delva A, Van Weehaeghe D, Koole M, Van Laere K, Vandenberghe W. Delva A, et al. Mov Disord. 2020 Nov;35(11):1977-1986. doi: 10.1002/mds.28216. Epub 2020 Aug 7. Mov Disord. 2020. PMID: 32767618

5

Synaptic density in healthy human aging is not influenced by age or sex: a ¹¹C-UCB-J PET study.

Michiels L, Delva A, van Aalst J, Ceccarini J, Vandenberghe W, Vandenbulcke M, Koole M, Lemmens R, Laere KV. Michiels L, et al. Among authors: delva a. Neuroimage. 2021 May 15;232:117877. doi: 10.1016/j.neuroimage.2021.117877. Epub 2021 Feb 24. Neuroimage. 2021. PMID: 33639258 Free article.

6

Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study.

Delva A, Michiels L, Koole M, Van Laere K, Vandenberghe W. Delva A, et al. Neurology. 2022 Jan 4;98(1):e83-e94. doi: 10.1212/WNL.0000000000012969. Epub 2021 Oct 18. Neurology. 2022. PMID: 34663644

7

Parkinson's Disease with a Homozygous PARK7 Mutation and Clinical Onset at the Age of 5 Years.

Delva A, Race V, Boon E, Van Laere K, Vandenberghe W. Delva A, et al. Mov Disord Clin Pract. 2020 Dec 2;8(1):149-152. doi: 10.1002/mdc3.13114. eCollection 2021 Jan. Mov Disord Clin Pract. 2020. PMID: 34869787 Free PMC article. No abstract available.

8

Longitudinal Positron Emission Tomography Imaging of Presynaptic Terminals in Early Parkinson's Disease.

Delva A, Van Laere K, Vandenberghe W. Delva A, et al. Mov Disord. 2022 Sep;37(9):1883-1892. doi: 10.1002/mds.29148. Epub 2022 Jul 12. Mov Disord. 2022. PMID: 35819412

9

Longitudinal Imaging of Regional Brain Volumes, SV2A, and Glucose Metabolism In Huntington's Disease.

Delva A, Van Laere K, Vandenberghe W. Delva A, et al. Mov Disord. 2023 Aug;38(8):1515-1526. doi: 10.1002/mds.29501. Epub 2023 Jun 29. Mov Disord. 2023. PMID: 37382295

10

Mild Motor Signs in Healthy Aging Are Associated with Lower Synaptic Density in the Brain.

Van Cauwenberge MGA, Delva A, Vande Casteele T, Laroy M, Radwan A, Vansteelandt K, Van den Stock J, Bouckaert F, Van Laere K, Emsell L, Vandenberghe W, Vandenbulcke M. Van Cauwenberge MGA, et al. Among authors: delva a. Mov Disord. 2023 Oct;38(10):1786-1794. doi: 10.1002/mds.29570. Epub 2023 Aug 13. Mov Disord. 2023. PMID: 37574924

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page